However, another study revealed that the expression of miR-296-5p was obviously increased in glioblastoma, while downregulation of miR-296-5p increased the sensitivity of esophageal cancer cells to both P-glycoprotein-related and P-glycoprotein-nonrelated drugs18. This evidence concerns the gene ABCB1 and glioblastoma.